QuantuMDx

From the QuantuMDx team, thank you for another great year. Here's to a prosperous 2025. ✨   #SeasonsGreetings #MerryChristmas #NewYear

An alternative Christmas Future: Is #AMR the Ghost of Christmas Yet to Come? 👻 As the end of 2024 approaches, we present the classic tale, A Christmas Carol, through an AMR lens. 😱 Similar to Scrooge’s final ghostly visitation, AMR is a wake-up call to the reality of life without antibiotics. Yet, there are many reasons to be hopeful that AMR is preventable from becoming the spectre that it could be. We look forward to seeing innovations and the result of multidisciplinary working translate from the page and into everyday practice, during 2025 and beyond. 

🤝 Collective efforts across finance, policy, regulation, scientific research and clinical practice are critical in addressing the threat of antimicrobial resistance.   📑 Our 'WHO AMR Priorities' series concludes with a summary of the 12 collaborative research priorities that span these multiple disciplines. #WHO #AMR #Collaboration

Happy Christmas Jumper Day to those who celebrate! QuantuMDx have come together to spread festive cheer and raise money for Save the Children UK. A perfect way to brighten up this foggy December day with all the bold prints and sparkles. ✨🎅 #ChristmasJumperDay #SavetheChildren #TeamSpirit

🧪 Research into diagnostics of infections was named as one of the priority areas in the WHO AMR global research agenda 2023. 🦠 Our fourth slide deck of the 'WHO AMR Priorities' series looks deeper into some of the key areas of infectious disease diagnostic research where the WHO is calling for more strategic interventions, such as implementation of point-of-care testing, including for detection of Neisseria gonorrhoeae. #WHO #AMR #Diagnostics

NEW TB DATA: Tuberculosis (TB) has risen by 11% in 2023 compared to 2022. 📈 While England remains a low-incidence country, we have seen an increase in drug-resistant TB, requiring longer and more complex treatment. 💊 Read the full report 📃 https://lnkd.in/eSWBdSPE

👀

📑 In 2023, WHO published a policy brief on the global research agenda for antimicrobial resistance (AMR) in human health. It prioritises 40 research topics, which can be categorised into five main areas, to guide key stakeholders in generating new evidence that will inform future AMR policies and interventions.  🔍 The third carousel of our 'WHO AMR Priorities' series looks at one of these five research areas: Drug-resistant Tuberculosis.  #WHO #AMR #TB

We are currently looking to recruit three new QA Officers. For more information about the role, see our website linked here: https://lnkd.in/ekyiHxgR To apply, send a cover letter and CV to recruitment@quantumdx.com.

❔ Did you know, WHO were the first to systematically categorise fungal pathogens into priority groups for the fight against antimicrobial resistance? 💊 In the second of our 'WHO AMR Priorities' carousel series, we present the fungal pathogens listed by WHO according to their public health importance and antifungal resistance. 🔎 Let's take a look. #WAAW2024 #WHO #AMR